CTOs on the Move

FORCE Therapeutics

www.forcetherapeutics.com

 
FORCE Therapeutics is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

FORCE Therapeutics raised $21M on 11/07/2018

Similar Companies

AART

AART is a Reno, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NanoHybrids

NanoHybrids specializes in research and commercialization of nanotechnology-based products that enhance diagnosis and therapy for cancer and other diseases through enhanced molecular imaging and profiling. Our molecular imaging nanoparticles enhance contrast in vitro and in vivo across multiple biomedical imaging modalities. We are the leading provider of silica-coated gold nanoparticles optimized for photoacoustic (optoacoustic) imaging. With conjugation services we provide nanoparticles with high specificity for targeted cell receptors and tailored to individual applications. Our nanoparticles improve signal strength and allow real time imaging of functional biology. Interested in learning how we are using nanotechnology to drive advances in the life-sciences? Want learn more about our research, products, or services? Contact us, and let`s talk.

Septodont Inc

Septodont Inc is a Cambridge, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VentriFlo

The VentriFlo True Pulse Pump is a novel, truly pulsatile blood pumping system designed to achieve superior outcomes, reduce costs and improve safety for pediatric & adult patients who require cardiopulmonary support during surgery or in the ICU.

Essilor

The world`s leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. To support this mission, Essilor allocates more than €200 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Its flagship brands are Varilux®, Crizal®, Transitions®, Eyezen™, Xperio®, Foster Grant®, Bolon™ and Costa®. It also develops and markets equipment, instruments and services for eyecare professionals. Essilor reported consolidated revenue of more than €7.1 billion in 2016 and employs 64,000 people worldwide. It markets its products in more than 100 countries and has 33 plants, 490 prescription laboratories and edging facilities, as well as five research and development centers around the world.